Elbaz, Tamer <br/><br/>
Efficacy and safety of sofosbuvir and daclatasvir with or without ribavirin in elderly patients with chronic hepatitis C virus infection.  [electronic resource] 

 -  Journal of medical virology  02 2019 
 - 272-277 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1096-9071 
<br/><br/><label>Standard No.: </label>10.1002/jmv.25287  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--administration & dosage<br/>Carbamates<br/>Drug Therapy, Combination--adverse effects<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Imidazoles--administration & dosage<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Pyrrolidines<br/>Ribavirin--administration & dosage<br/>Sofosbuvir--administration & dosage<br/>Treatment Outcome<br/>Valine--analogs & derivatives